Castill Health Announces Plans for Philippines Digital Healthcare Launch, Supported by Craig Astill and Caason Group 
PDF to PPT Converter From Presentations.AI Turns PDFs Into Editable PowerPoint Slide Decks With AI, Keeping Charts, Tables and Images Intact, as a Free-to-Try Gamma and Beautiful.ai Alternative 
Hong Kong Autumn Electronics Fair and electronicAsia attract over 61,000 buyers for sourcing, business opportunities Enzo Biochem Appoints Matthew Kupferberg as General Counsel
NEW YORK, NY, Aug. 03, 2022 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo”…
BioAtla to Participate in the 2022 BTIG Biotechnology Conference
SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) — BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage…
Cornerstone Pharmaceuticals Announces Successful Completion of Phase 1b Clinical Trial for CPI-613® (Devimistat) in Combination with Gemcitabine and Cisplatin in Patients with Biliary Tract Cancer
CRANBURY, N.J., Aug. 03, 2022 (GLOBE NEWSWIRE) — Cornerstone Pharmaceuticals, Inc. (“Cornerstone” or the “Company”),…
Morphic Announces Corporate Highlights and Financial Results for the Second Quarter 2022
Continued enrollment of EMERALD-1 phase 2a trial of MORF-057 in patients with ulcerative colitis Announced…
Landos Biopharma Reports Positive Top-Line Results From NX-13 Phase 1b Trial
NX-13 Demonstrated Favorable Safety and Tolerability Profile Across Range of Once-Daily Doses Results Indicate Promising…
Ocuphire Extends U.S. Patent Protection for Late-Stage Drug Candidate Nyxol® for Reversal of Mydriasis by Five More Years into 2039 with New Patent Issuance
Issuance Extends Nyxol’s U.S. Patent Protection from 2034 into 2039 for RM Indication Growing Patent…
Vericel Reports Second Quarter 2022 Financial Results
Second Quarter Total Net Revenue of $37.0 Million MACI Net Revenue of $28.6 Million Conference…
Todos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista Diagnostics
§ Lesion swab (standard of care) and saliva-based sample collection planned § Peer-reviewed publication demonstrating saliva testing…
Acerus to Report Q2-2022 Financial Results and Host Investor Call
TORONTO, Aug. 03, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (TSX:ASP; OTCQB:ASPCF) will announce its…
Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
– ARCALYST® (rilonacept) net revenue of $27.0 million in Q2 2022 – – ARCALYST full-year…
AEON Biopharma Raises $30 Million from Insiders
Brings Total Capital Raised Since December 2021 to $54.5 Million IRVINE, Calif., Aug. 03, 2022…
MediWound Announces U.S. FDA Acceptance of Biologics License Application for NexoBrid for the Treatment of Severe Thermal Burns
Prescription Drug User Fee Act (PDUFA) target date of January 1, 2023 YAVNE, Israel, Aug….
Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab
– Kiniksa to receive $100 million in upfront and near-term payments – – Kiniksa is…
U.S. Patent Issued to HCW Biologics for Foundational Platform Technology
Issued Claims for Single-Chain Chimeric Polypeptide and Composition Claims for Lead Product Candidate, HCW9302 MIRAMAR, Fla.,…
Clearside Biomedical to Participate in Three Upcoming Investor Conferences in August 2022
ALPHARETTA, Ga., Aug. 03, 2022 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing…
Tilray Wellness Announces U.S. Distribution Agreement with Southern Glazer’s Wine & Spirits for CBD Beverages
NEW YORK, Aug. 03, 2022 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray” or the “Company”)…
Roivant Sciences to Report Financial Results for the Quarter Ended June 30, 2022 on Monday, August 15, 2022
Investor call and webcast scheduled for Monday, August 15 at 8:00 a.m. EDT Roivant will…
EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments
– First patient dosed in the Phase 2 DAVIO 2 clinical trial for wet age-related macular…
Surface Oncology Reports Financial Results and Business Highlights for Second Quarter 2022
– SRF388 clinical data presented at 2022 ASCO Annual Meeting demonstrated monotherapy responses in two…
Zentalis Pharmaceuticals to Participate in the Wedbush PacGrow Healthcare Conference
NEW YORK and SAN DIEGO, Aug. 03, 2022 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq:…